MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CGEM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cullinan Therapeutics (CGEM) Ownership - Who owns Cullinan Therapeutics?

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
One Main Street
Phone
+1 617 410-4650
Employees
109
Web
https://www.cullinantherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.06B
P/E Ratio
N/A
Total Cash
351.89M
Projected Growth
N/A
Total Debt
2.38M
Revenue
N/A
Risk (Beta)
-0.59
Dividend Yield
N/A
Total Cash/Share
5.73
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CGEM
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CGEM
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
One Main Street
Phone
+1 617 410-4650
Employees
109
Web
https://www.cullinantherapeutics.com